Depression Clinical Trials in New York

Showing 161-180 of 305 trials

Social Circumstances, Parenting Techniques, and Infant Development

NCT02121496

1. Investigators aim to assess a novel behavioral intervention (currently approved in Protocol #6285) behavioral intervention that promotes maternally-mediated behavioral changes in young infants to reduce the risk of postpartum depression in a group of low income women. More specifically, investigators aim to determine if a behavioral intervention targeting maternal caregiving of young infants can increase infant sleep and reduce fuss/cry behavior and thereby: (1) reduce the incidence and/or severity of postpartum maternal depression in low socioeconomic status (SES) women, and (2) improve the quality of mother-infant interaction and subsequent child development. Investigators will study: 1. The feasibility of applying this protocol with a low SES population 2. The effectiveness of the intervention compared to usual care 3. If the effects of the intervention can be detected in assessments of the quality of mother-infant interaction and infant neurocognitive development 2. Investigators aim to determine whether this behavioral intervention can affect infant development as measured by neurodevelopmental assessments and cortisol reactivity at 4 months of age.

Postpartum DepressionInfant DevelopmentRhythm; Sleep

New York State Psychiatric Institute60 participantsStarted Mar 2014

New York, New York, United States

COMPLETEDNA< 1 mile

Genomics Used to Improve DEpression Decisions

NCT02109939

Evaluate the impact of GeneSight Psychotropic on response to psychotropic treatment as judged by the mean change in the 17-item Hamilton Depression (HAM-D17) score from baseline to end of Week 8 of the study.

Major Depressive Disorder (MDD)

Assurex Health Inc.1,398 participantsStarted Apr 2014

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Bellflower, California, United States +58 more locations

Social Circumstances, Parenting Techniques, and Infant Development

Genomics Used to Improve DEpression Decisions

Depression Trials in Other Cities

Pediatric Open-Label Extension Study

Ketamine in the Treatment of Depression

Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)

Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder

Pilot Comparison of N-of-1 Trials of Light Therapy

Dichotic Listening as a Predictor of Medication Response in Depression

Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1

Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression

Digital Tools for Coping With Chronic Pain

A Long-Term Safety Study of ALKS 5461

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Low Field Magnetic Stimulation for Treatment Resistant Depression

A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)

Barriers to Mental Healthcare Utilization in Parkinson's Disease

Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder

Building Evidence-Based Supports for Teens Via Technology

Treatment for Teens With Alcohol Abuse and Depression

Ketamine for Major Depressive Disorder

Other Conditions in New York